Delivery Order SPE2DB24D2205-SPE2DB25FEDNM
Award Date
6/11/25
Potential Completion Date
7/3/25
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMIDRIA 1-0.3% VIAL 4ML, a pharmaceutical product. The contract has a ceiling value of $2,153.46 and is a firm fixed price, non-set-aside contract with a period of performance through June 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMIDRIA 1-0.3% VIAL 4ML, a pharmaceutical product, with a ceiling value of $2,153.46 and a completion date of June 18, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there is no...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OMIDRIA 1-0.3% vials. The contract has a ceiling value of $2,153.46 and an ultimate completion date of April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide 4,564,030,268 units of the pharmaceutical product OMIDRIA 1-0.3% VIAL 4ML. The delivery order has a ceiling value of $1,065.38 and a period of performance through April 10, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp. The contract is for the procurement of OMIDRIA 1-0.3% VIAL 4ML, a specialty pharmaceutical product, with a ceiling value of $5,326.90 and a period of performance through December 9, 2024. The contract was awarded on November 15, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of OMIDRIA 1-0.3% vials, a prescription ophthalmic drug, with a ceiling value of $4,261.52. The contract has an ultimate completion date of September 12, 2024. This contract is not set aside for any special business categories. AmerisourceBergen, through its extensive supply chain network,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $9,566.32 contract is for the delivery of OMIDRIA 1-0.3% VIAL 4ML, a medical supply, with a completion date of June 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMVOH 100 MG/ML PENML, a pharmaceutical product, with a ceiling value of $30,984.01 and a performance period ending on May 30, 2025. The contract is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of OMNIPAQUE 180 MG/ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $1,332.36 and a performance period ending on June 23, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any specific business type. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $144,092.87 and is for the supply of the pharmaceutical product "OMVOH 100 MG/ML PENML." The ultimate completion date for this contract is June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...